Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) dropped 3.8% on Friday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The company has a market capitalization of C$52.28 million and a PE ratio of -0.37. The firm’s fifty day simple moving average is C$0.26 and its 200 day simple moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Breakout Stocks: What They Are and How to Identify Them
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Top Biotech Stocks: Exploring Innovation Opportunities
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Investing in Commodities: What Are They? How to Invest in Them
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
